Upstream Bio (UPB) Equity Ratio: 2023-2025

Historic Equity Ratio for Upstream Bio (UPB) over the last 1 years, with Sep 2025 value amounting to 0.97.

  • Upstream Bio's Equity Ratio rose 240.48% to 0.97 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.97, marking a year-over-year increase of 240.48%. This contributed to the annual value of 0.98 for FY2024, which is 192.84% up from last year.
  • As of Q3 2025, Upstream Bio's Equity Ratio stood at 0.97, which was down 0.44% from 0.97 recorded in Q2 2025.
  • Upstream Bio's Equity Ratio's 5-year high stood at 0.98 during Q1 2025, with a 5-year trough of -1.05 in Q4 2023.
  • Over the past 3 years, Upstream Bio's median Equity Ratio value was 0.97 (recorded in 2025), while the average stood at 0.36.
  • Data for Upstream Bio's Equity Ratio shows a peak YoY spiked of 240.48% (in 2025) over the last 5 years.
  • Upstream Bio's Equity Ratio (Quarterly) stood at -1.05 in 2023, then skyrocketed by 192.84% to 0.98 in 2024, then spiked by 240.48% to 0.97 in 2025.
  • Its Equity Ratio was 0.97 in Q3 2025, compared to 0.97 in Q2 2025 and 0.98 in Q1 2025.